180 related articles for article (PubMed ID: 35132844)
1. Nationwide Survey for Current Status of Laboratory Diagnosis of
Chung HS; Park JS; Shin BM; Yoo HM; Kim H; Cho J; Lee CH; Ryoo NH; Kim JS; Chung JW; Hong KH; Kim YS; Cho YS
J Korean Med Sci; 2022 Feb; 37(5):e38. PubMed ID: 35132844
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Diagnosis of
Chung HS; Park JS; Shin BM
Ann Lab Med; 2019 May; 39(3):317-321. PubMed ID: 30623624
[TBL] [Abstract][Full Text] [Related]
3. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
4. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
[TBL] [Abstract][Full Text] [Related]
5. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
[TBL] [Abstract][Full Text] [Related]
7. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Diagnostic Methods for
Chung HS; Park JS; Shin BM
Ann Lab Med; 2021 Mar; 41(2):171-180. PubMed ID: 33063678
[TBL] [Abstract][Full Text] [Related]
9. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
10. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
Perry MD; White PL; Morris TE
Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
12. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
[TBL] [Abstract][Full Text] [Related]
13. The Laboratory Diagnosis of Clostridioides difficile Infection: An update of current laboratory practice.
Somily AM; Khan MA; Morshed M
J Infect Dev Ctries; 2021 Oct; 15(10):1364-1375. PubMed ID: 34780357
[TBL] [Abstract][Full Text] [Related]
14. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
17. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
[TBL] [Abstract][Full Text] [Related]
18. Potential underreporting of treated patients using a
Guh AY; Fridkin S; Goodenough D; Winston LG; Johnston H; Basiliere E; Olson D; Wilson CD; Watkins JJ; Korhonen L; Gerding DN
Infect Control Hosp Epidemiol; 2024 May; 45(5):590-598. PubMed ID: 38268440
[TBL] [Abstract][Full Text] [Related]
19. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
Garvey MI; Bradley CW; Wilkinson MAC; Holden E
Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
[TBL] [Abstract][Full Text] [Related]
20. A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.
Han Z; McMullen KM; Russo AJ; Copper SM; Warren DK; Dubberke ER
Am J Infect Control; 2012 May; 40(4):349-53. PubMed ID: 21794950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
